Company Profile
Ethos Biosciences, Inc
Company Overview
Ethos Biosciences was formed in 2018 as a subsidiary of Ott Scientific to focus on the design, development, and manufacture of high-quality, easy-to-use assays. Building from our acquisition of Exocell, Ethos Biosciences seeks to drive healthcare innovation in nephrology by providing diagnostic tools for scientists and practitioners in two ways. First, we facilitate research in nephrology by manufacturing RUO assays for kidney disease markers that are distributed globally to the research community. Second, we research and develop clinical diagnostics for novel indications to diagnose kidney disease. Our vision is to be the leading provider of research and clinical assays for kidney disease.
Our R&D headquarters is in Newtown Square, PA, and manufacturing is in Swedesboro, NJ. Both sites are brand new fit-outs and prepared for growth. We are seeking candidates that enthusiastically embody our core competencies: smart, hard work, grit, and integrity. Contact us to learn more about joining the Ethos Biosciences family.
Company History
1961 - Incorporation of Polysciences, Inc
1993 - Acquisition of Polysciences by Michael H. Ott
2003 - Acquisition of Bangs Laboratories
2004 - Acquisition of Dream Cosmetics
2005 - Acquisition of Dionis Goatmilk Soap Company
2011 - Formation of Polysciences Asia-Pacific
2014 - Formation of Creative Consumer Products
2016 - Formation of The Ott Group
2015 - Acquisition of Astral Diagnostics
2018 - Formation of Ethos Biosciences
2018 - Acquisition of Exocell
2019 - Name change of The Ott Group to Ott Scientific
Notable Products / Brands
Ethos Biosciences; Exocell
Notable Clients
Top Pharma, Biotech, Academic, and Research Institutions